MRgLITT for mTLE: A PROBE Trial

Recruiting N/A Interventional Study
Temporal Lobe Epilepsy (TLE)
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
120 (estimated)
Sponsor
Beijing Tiantan Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

How does magnetic resonance-guided laser interstitial thermal therapy (MRgLITT) impact clinical prognosis in mesial temporal lobe epilepsy (mTLE)?

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * 18-65 years. * Drug-resistant mesial temporal lobe epilepsy. * Seizure frequency ≥ 1 time /month. * Participants approved. Exclusion Criteria: * History of brain surgery. * Intracranial space occupying lesions. * Individuals with significant medical comorbidities or conditio…
Contacts

Kai Zhang, Dr.

86 01059975051

zhangkai62035@sina.com

CONTACT